ClinicalTrials.Veeva

Menu

Clinical Features of COVID-19 Patients

S

San Salvatore Hospital of L'Aquila

Status

Completed

Conditions

Ventilatory Failure
Acute Respiratory Distress Syndrome
Covid19

Treatments

Diagnostic Test: peripheral lymphocytes subsets

Study type

Observational

Funder types

Other

Identifiers

NCT04815304
26100/21

Details and patient eligibility

About

The data were retrospectively collected during the first and the second wave of epidemic in COVID-19 patients with Severe Acute Respiratory Syndrome Coronavirus 2, at the moment of intensive care unit admission and during the in intensive care unit staying.

Full description

At the moment of intensive care unit admission and during the in intensive care unit staying, the following data were collected: peripheral lymphocyte subsets were measured by multiple-color flow cytometry, chest computed tomography and ultrasonography scans, arterial blood gas parameters (pH, partial pressure of carbon dioxide, partial pressure of oxygen, concentration of hydrogen carbonate, base excess, and arterial oxygen saturation), and pain assessed by using numeric rating scale.

Enrollment

200 patients

Sex

All

Ages

18 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • COVID-19 patients
  • Acute respiratory distress syndrome
  • needing of ventilatory support

Exclusion criteria

  • asymptomatic COVID-19 patients
  • few symptoms
  • mild symptoms
  • without needing of ventilatory support

Trial contacts and locations

1

Loading...

Central trial contact

Franco Marinangeli, MD; Emiliano Petrucci, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems